Skip to main content

Jens Meiler Archives

Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level

Apr. 18, 2018—A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger.

Read more


New working group to assess and prioritize opportunities for enhancing research IT resources on campus

Mar. 17, 2017—The Research IT Special Project Working Group will advance the efforts of the Provost’s Initiative to Enhance Research and Scholarship, or PIERS.

Read more


Transcription factor evolution

Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.

Read more


‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

Jun. 2, 2016—High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

Read more


Potent HIV antibodies suggest new vaccine development approach

Apr. 7, 2016—It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.

Read more


Dynamics of a drug resistance transporter

Feb. 5, 2016—Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance.

Read more


Chemist Jens Meiler receives Humboldt Foundation award

Dec. 15, 2015—Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany.

Read more


‘Redesigned’ antibodies may control HIV: study

May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.

Read more


VU lands $9 million NIH grant to design better flu vaccines

May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.

Read more


Members named to Academic Strategic Plan committees

Oct. 27, 2014—Two committees tasked with fleshing out key initiatives in Vanderbilt’s Academic Strategic Plan are now staffed and ready to begin work.

Read more


New undergraduate and faculty research collaborations inspire, inform

Apr. 29, 2014—The Littlejohn Family Undergraduate Research Program enables Arts and Science undergraduates to conduct original research alongside faculty fellows.

Read more


VU researchers report G protein advancement that could lead to more effective drugs

Dec. 2, 2013—Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs.

Read more


Page 1 of 212

Upcoming Events

MORE EVENTS »